BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 31 found
  Current Search:  thalomid: 31     

HTML
100%
Celgene shares drop as Baird issues downgrade
NEW YORK (AP) -- Robert W.

Baird & Co.

analyst Christopher Raymond downgraded shares of Celgene Corp.

Tuesday, saying sales of the key revenue driver Revlimid could fall short of expectations in 2009.

Raymond cut the rating to ...

Yahoo!:  Jan 7 2009 12:06AM
Matching: thalomid
Find similar documents
HTML
100%
Celgene shares slip as Baird issues downgrade
NEW YORK (AP) -- Robert W.

Baird & Co.

analyst Christopher Raymond downgraded shares of Celgene Corp.

Tuesday, saying sales of the key revenue driver Revlimid could fall short of expectations in 2009.

Raymond cut the rating to ...

Yahoo!:  Jan 6 2009 4:17PM
Matching: thalomid
Find similar documents
HTML
100%
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
- (NewsRx.com) -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research released by Avalere Health and...
Pharmacy Choice:  Dec 21 2008 7:27PM
Matching: thalomid
Find similar documents
HTML
100%
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
Latest Health News WASHINGTON, Dec.

12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009,...

Montana's News Station:  Dec 14 2008 4:03PM
Matching: thalomid
Find similar documents
HTML
100%
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
The Avalere-ACS CAN research found that Medicare stand-alone prescription drug plans (PDPs) have been increasingly shifting name-brand oral cancer drugs to higher formulary tiers over the last four years, meaning that with each year, the...
NewsBlaze:  Dec 13 2008 12:06AM
Matching: thalomid
Find similar documents
HTML
100%
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON The Avalere-ACS CAN research found that Medicare stand-alone prescription drug plans (PDPs) have been increasingly shifting name-brand oral cancer drugs to higher formulary tiers over the last four years, meaning that with each...
Red Orbit:  Dec 12 2008 11:50PM
Matching: thalomid
Find similar documents
HTML
100%
Prescription Drug Benefits For Cancer Medicare Patients To Cost More In 2009
People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research released today by Avalere Health and the American...
EMax Health:  Dec 13 2008 8:22PM
Matching: thalomid
Find similar documents
HTML
100%
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
KSLA Health Connections Health WASHINGTON, Dec.

12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in...

KSLA:  Dec 13 2008 7:45PM
Matching: thalomid
Find similar documents
HTML
100%
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
Latest Health News WASHINGTON, Dec.

12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009,...

KLFY:  Dec 13 2008 2:49PM
Matching: thalomid
Find similar documents
HTML
100%
Prescription Drug Benefits For Medicare Patients With Cancer To Cost More In 2009
People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research released by Avalere Health and the American Cancer...
Medical News Today:  Dec 13 2008 12:12PM
Matching: thalomid
Find similar documents
HTML
100%
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON, Dec.

12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research...

TickerTech.com:  Dec 12 2008 10:44PM
Matching: thalomid
Find similar documents
HTML
100%
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
/PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research released today by...
Pharma Live:  Dec 12 2008 7:45PM
Matching: thalomid
Find similar documents
HTML
100%
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON, Dec.

12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research...

PR Newswire:  Dec 12 2008 7:44PM
Matching: thalomid
Find similar documents
HTML
100%
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON, Dec.

12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research...

San Antonio Business Journal:  Dec 12 2008 7:14PM
Matching: thalomid
Find similar documents
HTML
100%
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON, Dec.

12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research...

Portland Business Journal:  Dec 12 2008 6:52PM
Matching: thalomid
Find similar documents
HTML
100%
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON, Dec.

12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research...

Nashville Business Journal:  Dec 12 2008 6:48PM
Matching: thalomid
Find similar documents
HTML
100%
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON, Dec.

12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research...

Cincinnati Business Journal:  Dec 12 2008 6:44PM
Matching: thalomid
Find similar documents
HTML
100%
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON, Dec.

12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research...

Street Insider:  Dec 12 2008 6:43PM
Matching: thalomid
Find similar documents
HTML
100%
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON, Dec.

12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research...

San Francisco Business Times:  Dec 12 2008 6:40PM
Matching: thalomid
Find similar documents
HTML
100%
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research released today by Avalere Health and the American...
The Business Journal Phoenix:  Dec 12 2008 6:39PM
Matching: thalomid
Find similar documents
HTML
100%
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON, Dec.

12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research...

Atlanta Business Chronicle:  Dec 12 2008 6:34PM
Matching: thalomid
Find similar documents
HTML
100%
Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
WASHINGTON, Dec.

12 /PRNewswire-USNewswire/ -- People with cancer enrolled in Medicare Part D plans will spend more out-of-pocket for their Part D drugs and face increased restrictions on access to them in 2009, according to new research...

Biz Journals:  Dec 12 2008 6:26PM
Matching: thalomid
Find similar documents
HTML
100%
Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of Ameri
Paul Richardson presents combined results from a Phase 1/2 study of perifosine in combination with bortezomib (+/- dexamethasone) in multiple myeloma patients relapsed from or refractory to bortezomib NEW YORK, Dec.

9 /PRNewswire-FirstCall...

Yahoo! Canada:  Dec 9 2008 5:12PM
Matching: thalomid
Find similar documents
HTML
100%
Alzheimer's Drug Discovery Foundation Funds P2D to Develop Anti-Alzheimer's Disease Drug
NEW YORK, NY -- (Marketwire) -- 12/02/08 -- The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it is providing a biotechnology founder's grant of $300,000 to P2D Biosciences (P2D), a start-up biotechnology company...
Houston Chronicle:  Dec 2 2008 11:11PM
Matching: thalomid
Find similar documents
HTML
100%
Alzheimer's Drug Discovery Foundation Funds P2D to Develop Anti-Alzheimer's Disease Drug
NEW YORK, NY, December 2 / MARKET WIRE/ -- The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it is providing a biotechnology founder's grant of $300,000 to P2D Biosciences (P2D), a start-up biotechnology company dedicated...
Therapeutics Daily:  Dec 2 2008 11:05PM
Matching: thalomid
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.